Medical International Technology Inc. "MIT" announces that it has completed its 10QSB quarterly reports and has become up to date with its filings

Friday, November 16, 2007 General News
Email Print This Page Comment
Font : A-A+

DENVER, CO, Nov. 15 /PRNewswire-FirstCall/ - Medical InternationalTechnology Inc. (MDLH. PK) (http://www.mitcanada.ca http://www.mitinvest.ca),is pleased to announce that it has completed its 10QSB quarterly reports(December 2006, March 2007 and June 2007) and has become up to date with itsfilings.

Medical International Technology Inc. is pleased to continue providing asafe and effective means to help prevent the spread of deadly diseases to bothhumans and animals through the use of the MED-JET(R) and AGRO-JET(R)needle-free injection systems.

Karim Menassa, President

On Behalf of the Board of Directors

About Medical International Technology, Inc. MIT CANADA, with offices inMontreal, is a subsidiary of Denver, Colorado-based Medical InternationalTechnology, Inc. (MIT USA), which specializes in the development, production,marketing and sale of needle-free injectors both for humans and animals, forindividual and mass vaccinations.

The statements which are not historical facts contained in this pressrelease are forward-looking statements that involve certain risks anduncertainties, including but not limited to risks associated with theuncertainty of future financial results, additional financing requirements,development and acquisition of new product lines and services, governmentapproval processes, the impact of competitive products or pricing atechnological changes, the effect of economic conditions and otheruncertainties, and the risk factors set forth from time to time in theCompany's SEC reports, including but not limited to its annual report on Form10-KSB; its quarterly reports on Forms 10-QSB; and any reports on Form 8-K.Medical International Technology Inc. takes no obligation to update or correctforward-looking statements.

SOURCE MEDICAL INTERNATIONAL TECHNOLOGIES INC.


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook